106 related articles for article (PubMed ID: 37720047)
1. Disentangling accelerated cognitive decline from the normal aging process and unraveling its genetic components: A neuroimaging-based deep learning approach.
Dai Y; Yu-Chun H; Fernandes BS; Zhang K; Xiaoyang L; Enduru N; Liu A; Manuel AM; Jiang X; Zhao Z
Res Sq; 2023 Sep; ():. PubMed ID: 37720047
[TBL] [Abstract][Full Text] [Related]
2. Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach.
Dai Y; Hsu YC; Fernandes BS; Zhang K; Li X; Enduru N; Liu A; Manuel AM; Jiang X; Zhao Z;
J Alzheimers Dis; 2024; 97(4):1807-1827. PubMed ID: 38306043
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset.
Homann J; Osburg T; Ohlei O; Dobricic V; Deecke L; Bos I; Vandenberghe R; Gabel S; Scheltens P; Teunissen CE; Engelborghs S; Frisoni G; Blin O; Richardson JC; Bordet R; Lleó A; Alcolea D; Popp J; Clark C; Peyratout G; Martinez-Lage P; Tainta M; Dobson RJB; Legido-Quigley C; Sleegers K; Van Broeckhoven C; Wittig M; Franke A; Lill CM; Blennow K; Zetterberg H; Lovestone S; Streffer J; Ten Kate M; Vos SJB; Barkhof F; Visser PJ; Bertram L
Front Aging Neurosci; 2022; 14():840651. PubMed ID: 35386118
[TBL] [Abstract][Full Text] [Related]
4. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
5. Single-nucleotide polymorphisms are associated with cognitive decline at Alzheimer's disease conversion within mild cognitive impairment patients.
Lee E; Giovanello KS; Saykin AJ; Xie F; Kong D; Wang Y; Yang L; Ibrahim JG; Doraiswamy PM; Zhu H
Alzheimers Dement (Amst); 2017; 8():86-95. PubMed ID: 28560309
[TBL] [Abstract][Full Text] [Related]
6. Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer's Disease.
Daunt P; Ballard CG; Creese B; Davidson G; Hardy J; Oshota O; Pither RJ; Gibson AM
J Prev Alzheimers Dis; 2021; 8(1):78-83. PubMed ID: 33336228
[TBL] [Abstract][Full Text] [Related]
7. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
Elife; 2023 Jan; 12():. PubMed ID: 36607335
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation and neuroimaging measures in Alzheimer disease.
Biffi A; Anderson CD; Desikan RS; Sabuncu M; Cortellini L; Schmansky N; Salat D; Rosand J;
Arch Neurol; 2010 Jun; 67(6):677-85. PubMed ID: 20558387
[TBL] [Abstract][Full Text] [Related]
9. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
[TBL] [Abstract][Full Text] [Related]
10. Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2017 Apr; 13(4):e1-e85. PubMed ID: 28342697
[TBL] [Abstract][Full Text] [Related]
11. Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer's Disease or Mild Cognitive Impairment.
Li L; Yang Y; Zhang Q; Wang J; Jiang J; Neuroimaging Initiative AD
Behav Neurol; 2021; 2021():3359103. PubMed ID: 34336000
[TBL] [Abstract][Full Text] [Related]
12. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
[TBL] [Abstract][Full Text] [Related]
13. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
[TBL] [Abstract][Full Text] [Related]
14. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
[TBL] [Abstract][Full Text] [Related]
15. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2012 Feb; 8(1 Suppl):S1-68. PubMed ID: 22047634
[TBL] [Abstract][Full Text] [Related]
16. c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease.
Jemimah S; AlShehhi A;
BMC Med Genomics; 2023 Oct; 16(Suppl 2):244. PubMed ID: 37833700
[TBL] [Abstract][Full Text] [Related]
17. An unsupervised learning approach to diagnosing Alzheimer's disease using brain magnetic resonance imaging scans.
Liu Y; Mazumdar S; Bath PA;
Int J Med Inform; 2023 May; 173():105027. PubMed ID: 36921480
[TBL] [Abstract][Full Text] [Related]
18. Using high-dimensional machine learning methods to estimate an anatomical risk factor for Alzheimer's disease across imaging databases.
Casanova R; Barnard RT; Gaussoin SA; Saldana S; Hayden KM; Manson JE; Wallace RB; Rapp SR; Resnick SM; Espeland MA; Chen JC;
Neuroimage; 2018 Dec; 183():401-411. PubMed ID: 30130645
[TBL] [Abstract][Full Text] [Related]
19. Deep learning prediction of mild cognitive impairment conversion to Alzheimer's disease at 3 years after diagnosis using longitudinal and whole-brain 3D MRI.
Ocasio E; Duong TQ
PeerJ Comput Sci; 2021; 7():e560. PubMed ID: 34141888
[TBL] [Abstract][Full Text] [Related]
20. Association between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer's disease.
Liu Y; Yu JT; Wang HF; Hao XK; Yang YF; Jiang T; Zhu XC; Cao L; Zhang DQ; Tan L
PLoS One; 2014; 9(12):e114777. PubMed ID: 25486118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
